Colistin-nonsusceptible Pseudomonas aeruginosa sequence type 654 with blaNDM-1 arrives in North America

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 3, 2016, Pages 1794-1800

  Mataseje, L F ^a   Peirano, G ^b   Church, D L ^b,c,d   Conly, J ^b,c,d,e   Mulvey, M ^a   Pitout, J D ^b,c,e,f  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d Laboratory Medicine   (Canada)

^e Department of Pathology   (Canada)

^f UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE NDM 1; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; HYDROLASE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE NDM-1; CARBAPENEM DERIVATIVE;

AGED; ANTIBIOTIC SENSITIVITY; ARTERY THROMBOSIS; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BASILAR ARTERY; BRAIN INFARCTION; BROTH DILUTION; CASE REPORT; CLONE; COLISTIN NONSUSCEPTIBLE PSEUDOMONAS AERUGINOSA; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; ENDEMIC DISEASE; ESCHERICHIA COLI; GENE IDENTIFICATION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MALE; MINIMUM INHIBITORY CONCENTRATION; NEXT GENERATION SEQUENCING; NONHUMAN; NORTH AMERICA; PHENOTYPIC PLASTICITY; PNEUMONIA; PRIORITY JOURNAL; PROVIDENCIA RETTGERI; PSEUDOMONAS AERUGINOSA; RESPIRATORY DISTRESS; SCREENING; SLURRED SPEECH; TRACHEOSTOMY; TRAVEL; WEAKNESS; ANTIBIOTIC RESISTANCE; CANADA; DRUG EFFECTS; GENETICS; INDIA; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PLASMID; PROVIDENCIA;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CANADA; CARBAPENEMS; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PROVIDENCIA; PSEUDOMONAS AERUGINOSA;

EID: 84960157687     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02591-15     Document Type: Article

References (43)

1. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046-5054. http://dx.doi.org/10.1128/AAC.00774-09.
2. Johnson AP, Woodford N. 2013. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase NDM-mediated carbapenem resistance. J Med Microbiol 62:499-513. http://dx.doi.org/10.1099/jmm.0.052555-0.
3. Nordmann P, Poirel L, Walsh TR, Livermore DM. 2011. The emerging NDM carbapenemases. Trends Microbiol 19:588-595. http://dx.doi.org/10.1016/j.tim.2011.09.005.
4. NDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother 55:5403-5407. http://dx.doi.org/10.1128/AAC.00585-11.
5. NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 11:355-362. http://dx.doi.org/10.1016/S1473-3099 (11) 70059-7.
6. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 17:1791-1798. http://dx.doi.org/10.3201/eid1710.110655.
7. Nordmann P, Poirel L. 2014. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821-830. http://dx.doi.org/10.1111/1469-0691.12719.
8. Van der Bij AK, Pitout JD. 2012. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 67:2090-2100. http://dx.doi.org/10.1093/jac/dks214.
9. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement. M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. 2012. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol 50:3877-3880. http://dx.doi.org/10.1128/JCM.02117-12.
11. Mataseje LF, Bryce E, Roscoe D, Boyd DA, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Mounchili A, Simor A, Taylor G, Thomas E, Turgeon N, Mulvey MR, Canadian Nosocomial Infection Surveillance Program. 2012. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother 67:1359-1367. http://dx.doi.org/10.1093/jac/dks046.
12. Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, Bryce E, Gardam M, Nordmann P, Mulvey MR. 2004. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extendedspectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 48:3758-3764. http://dx.doi.org/10.1128/AAC.48.10.3758-3764.2004.
13. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219-228. http://dx.doi.org/10.1016/j.mimet.2005.03.018.
14. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. 2010. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 65:2518-2529. http://dx.doi.org/10.1093/jac/dkq347.
15. Peirano G, Pillai DR, Pitondo-Silva A, Richardson D, Pitout JD. 2011. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Dis 71:106-109. http://dx.doi.org/10.1016/j.diagmicrobio.2011.06.013.
16. Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. 2011. New Delhi metallo-beta-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis 17:103-106. http://dx.doi.org/10.3201/eid1701.101358.
17. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. 2011. Country-tocountry transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis 53:49-56. http://dx.doi.org/10.1093/cid/cir273.
18. Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout JD. 2013. Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother 57:3085-3091. http://dx.doi.org/10.1128/AAC.00297-13.
19. Pobiega M, Maciag J, Chmielarczyk A, Romaniszyn D, Pomorska-Wesolowska M, Ziolkowski G, Heczko PB, Bulanda M, Wojkowska-Mach J. 2015. Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa strains isolated from patients with urinary tract infections in southern Poland. Diagn Microbiol Infect Dis 83:295-297. http://dx.doi.org/10.1016/j.diagmicrobio.2015.07.022.
20. Samuelsen O, Toleman MA, Sundsfjord A, Rydberg J, Leegaard TM, Walder M, Lia A, Ranheim TE, Rajendra Y, Hermansen NO, Walsh TR, Giske CG. 2010. Molecular epidemiology of metallo-beta-lactamaseproducing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 54:346-352. http://dx.doi.org/10.1128/AAC.00824-09.
21. Wright LL, Turton JF, Livermore DM, Hopkins KL, Woodford N. 2015. Dominance of international 'high-risk clones' among metallo-betalactamaseproducing Pseudomonas aeruginosa in the UK. J Antimicrob Chemother 70:103-110. http://dx.doi.org/10.1093/jac/dku339.
22. NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother 55:3929-3931. http://dx.doi.org/10.1128/AAC.00226-11.
23. NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. Euro Surveill 17(45): pii=20311. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20311.
24. NDM-1-producing Pseudomonas aeruginosa sequence type ST235 from a stem cell transplant patient in Italy, May 2013. Euro Surveill 18(46): pii=20633. http://dx.doi.org/10.2807/1560-7917. ES2013.18.46.20633.
25. NDM-1 in the clinical isolates of Pseudomonas aeruginosa in India. J Clin Diagn Res 7:1328-1331. http://dx.doi.org/10.7860/JCDR/2013/5509.3137.
26. NDM-1) carbapenemase in Pseudomonas aeruginosa in a single centre in southern India. Indian J Med Res 140:546-550.
27. NDM-1-producing Pseudomonas aeruginosa in Egypt. Int J Infect Dis 29:80-81. http://dx.doi.org/10.1016/j.ijid.2014.07.008.
28. NDM-1, VIM-5 and VIM-6 metallobeta-lactamases in Denmark using whole-genome sequencing. Int J Antimicrob Agents 45:324-325. http://dx.doi.org/10.1016/j.ijantimicag.2014.11.004.
29. Turton JF, Wright L, Underwood A, Witney AA, Chan YT, Al-Shahib A, Arnold C, Doumith M, Patel B, Planche TD, Green J, Holliman R, Woodford N. 2015. High-resolution analysis by whole-genome sequencing of an international lineage (sequence type 111) of Pseudomonas aeruginosa associated with metallo-carbapenemases in the United Kingdom. J Clin Microbiol 53:2622-2631. http://dx.doi.org/10.1128/JCM.00505-15.
30. NDM-1 gene in a novel genetic context. Antimicrob Agents Chemother 57:3405-3407. http://dx.doi.org/10.1128/AAC.02312-12.
31. NDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from France. Antimicrob Agents Chemother 57:3408-3411. http://dx.doi.org/10.1128/AAC.02334-12.
32. Mishra S, Upadhyay S, Sen MR, Maurya AP, Choudhury D, Bhattacharjee A. 2015. Genetic acquisition of NDMgene offers sustainability among clinical isolates of Pseudomonas aeruginosa in clinical settings. PLoS One 10:e0116611. http://dx.doi.org/10.1371/journal.pone.0116611.
33. Carattoli A, Villa L, Poirel L, Bonnin RA, Nordmann P. 2012. Evolution of IncA/C blaCMY-(2)-carrying plasmids by acquisition of the blaNDM-(1) carbapenemase gene. Antimicrob Agents Chemother 56:783-786. http://dx.doi.org/10.1128/AAC.05116-11.
34. NDM-1 from Escherichia coli ST131. PLoS One 7:e34752. http://dx.doi.org/10.1371/journal.pone.0034752.
35. NDM-1, the ArmA 16S RNA methylase and a resistance-nodulation-cell division/multidrug efflux pump. J Antimicrob Chemother 68:34-39. http://dx.doi.org/10.1093/jac/dks357.
36. CTX-M-15 and qnrB1 genes. J Antimicrob Chemother 67:1645-1650. http://dx.doi.org/10.1093/jac/dks114.
37. Nakano R, Nakano A, Abe M, Inoue M, Okamoto R. 2012. Regional outbreak of CTX-M-2 beta-lactamase-producing Proteus mirabilis in Japan. J Med Microbiol 61:1727-1735. http://dx.doi.org/10.1099/jmm.0.049726-0.
38. Villa L, Carattoli A, Nordmann P, Carta C, Poirel L. 2013. Complete sequence of the IncT-type plasmid pT-OXA-181 carrying the blaOXA-181 carbapenemase gene from Citrobacter freundii. Antimicrob Agents Chemother 57:1965-1967. http://dx.doi.org/10.1128/AAC.01297-12.
39. NDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India. Antimicrob Agents Chemother 59:7387-7395. http://dx.doi.org/10.1128/AAC.01458-15.
40. NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 55:1274-1278. http://dx.doi.org/10.1128/AAC.01497-10.
41. Oueslati S, Nordmann P, Poirel L. 2015. Heterogeneous hydrolytic features for OXA-48-like beta-lactamases. J Antimicrob Chemother 70:1059-1063. http://dx.doi.org/10.1093/jac/dku524.
42. Potron A, Nordmann P, Lafeuille E, Al Maskari Z, Al Rashdi F, Poirel L. 2011. Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 55:4896-4899. http://dx.doi.org/10.1128/AAC.00481-11.
43. Kayama S, Koba Y, Shigemoto N, Kuwahara R, Kakuhama T, Kimura K, Hisatsune J, Onodera M, Yokozaki M, Ohge H, Sugai M. 2015. Imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae producing OXA-181 in Japan. Antimicrob Agents Chemother 59:1379-1380. http://dx.doi.org/10.1128/AAC.04330-14.